Activation of caspase-1 dependent interleukins in developmental brain trauma

Neurobiology of Disease

Volumn 25, Issue 3, 2007, Pages 614-622

  Sifringer, Marco ^a   Stefovska, Vanya ^a   Endesfelder, Stefanie ^a   Stahel, Philip F ^b   Genz, Kerstin ^c   Dzietko, Mark ^c   Ikonomidou, Chrysanthy ^a   Felderhoff Mueser, Ursula ^c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apoptosis; Caspase 1; Infant brain trauma; Interleukin 1 ; Interleukin 18

Indexed keywords

ANIMALS; APOPTOSIS; BRAIN; BRAIN INJURIES; CASPASE 1; INTERLEUKIN-18; INTERLEUKIN-1BETA; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NERVE DEGENERATION; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 33847283652     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.11.003     Document Type: Article

References (43)

1. Adelson P.D., and Kochanek P.M. Head injury in children. J. Child Neurol. 11 (1998) 2-15
2. Bittigau P., Sifringer M., Pohl D., Stadthaus D., Ishimaru M., Shimizu H., Ikeda M., Lang D., Speer A., Olney J.W., and Ikonomidou C. Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann. Neurol. 45 (1999) 724-735
3. Cai Z., Pan Z.L., Pang Y., Evans O.B., and Rhodes P.G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr. Res. 47 (2000) 64-72
4. De Olmos J.S., and Ingram W.R. An improved cupric-silver method for impregnation of axonal and terminal degeneration. Brain Res. 33 (1971) 523-529
5. Dinarello C.A. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am. J. Clin. Nutr. 83 (2006) 447S-455S
6. Dobbing J., and Sands J. The brain growth spurt in various mammalian species. Early Hum. Dev. 3 (1979) 70-84
7. Fantuzzi G., and Dinarello C.A. Interleukin-18 and interleukin-1 beta: 2 cytokine substrates for ICE (caspase-1). J. Clin. Immunol. 19 (1999) 1-11
8. Felderhoff-Mueser U., Sifringer M., Pesditschek S., Kuckuck H., Bittigau P., and Ikonomidou C. Pathways leading to apoptotic neurodegeneration following trauma to the developing brain. Neurobiol. Dis. 11 (2002) 231-245
9. Felderhoff-Mueser U., Sifringer M., Polley O., Dzietko M., Leineweber B., Mahler L., Baier M., Bittigau P., Obladen M., Ikonomidou C., and Bührer C. Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain. Ann. Neurol. 57 (2005) 50-59
10. Felderhoff-Mueser U., Schmidt O., Oberholzer A., Bührer C., and Stahel P. Interleukin-18 in brain injury: mechanisms of action in acute neurodegeneration. Trends Neurosci. 28 (2005) 487-493
11. Firsching R., and Woischneck D. Present status of neurosurgical trauma in Germany. World J. Surg. 25 (2001) 1221-1223
12. Goldstein M. Traumatic brain injury: a silent epidemic. Ann. Neurol. 27 (1990) 327
13. Hagberg H., Gilland E., Bona E., Hanson L.A., Hahn-Zoric M., Blennow M., Holst M., McRae A., and Soder O. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr. Res. 40 (1996) 603-609
14. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., and Moskowitz M.A. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal deamage. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2007-2012
15. Hedtjärn M., Leverin A.-L., Eriksson K., Blomgren K., Mallard C., and Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J. Neurosci. 22 (2002) 5910-5919
16. Holmin S., Schalling M., Hojeberg B., Nordqvist A.C., Skeftruna A.K., and Mathiesen T. Delayed cytokine expression in rat brain following experimental contusion. J. Neurosurg. 86 (1997) 493-504
17. Jander S., Schroeter M., and Stoll G. Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response. J Cereb. Blood Flow Metab. 22 (2002) 62-70
18. Koskiniemi M., Kyykka T., Nybo T., and Jarho L. Long-term outcome after severe brain injury in preschoolers is worse than expected. Arch. Pediatr. Adolesc. Med. 149 (1995) 249-254
19. Kuida K., Lippke J.A., Ku G., Harding M.W., Livingston D.J., Su M.S., and Flavell R.A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267 (1995) 2000-2003
20. Lebel-Binay S., Berger Y., Zinzindohoue F., Cugnene P., Thiounn N., Fridman W.H., and Pages F. Interleukin-18: biological properties and clinical implications. Eur. Cytokine Netw. 11 (2000) 15-26
21. Liu X.H., Kwon D., Schielke G.P., Yang G.Y., Silverstein F.S., and Barks J.D. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J. Cereb. Blood Flow Metab. 19 (1999) 1099-1108
22. Mah1y W.J., D'Souza B.J., Haller A., Rogers B.J., Epstein M.H., and Freeman J.M. Long-term outcome of children with severe head trauma and prolonged coma. Pediatrics 71 (1983) 756-762
23. Martin D., Chinookoswong N., and Miller G. The interleukin-1 receptors antagonist (rIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp. Neurol. 130 (1994) 362-367
24. Masson F., Thicoipe M., Aye P., Mokni T., Senjean P., Schmitt V., Dessalles P.H., Cazaugade M., and Labadens P. Epidemiology of severe brain injuries: a prospective population-based study. J. Trauma 51 (2001) 481-489
25. Menge T., Jander S., and Stoll G. Induction of the proinflammatory cytokine interleukin-18 by axonal injury. J. Neurosci. Res. 65 (2001) 332-339
26. Mori T., Wang X., Kline A.E., Siao C.J., Dixon C.E., Tsirka S.E., and Lo E.H. Reduced cortical injury and edema in tissue plasminogen activator knockout mice after brain trauma. NeuroReport 12 (2001) 4117-4120
27. Okamura H., Tsutsui H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., and Kurimoto M. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995) 91-99
28. Pohl D., Bittigau P., Ishimaru M.J., Stadthaus D., Hübner C., Olney J.W., Turski L., and Ikonomidou C. N-methyl-d-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2508-2513
29. Rabuffetti M., Sciorati C., Tarozzo G., Clementi E., Manfredi A.A., and Beltramo M. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl-ket1 induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokies. J. Neurosci. 20 (2000) 4398-4404
30. Schmidt O.I., Morganti-Kossmann M.C., Heyde C.E., Perez D., Yatsiv I., Shohami E., Ertel W., and Stahel P.F. Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injury. J. Neuroinflamm. 1 (2004) 13
31. Schmued L., Albertson C., and Slikker W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751 (1997) 37-46
32. Silverstein F.S., Barks J.D., Hagan P., Liu X.H., Ivacko J., and Szaflarski J. Cytokines and perinatal brain injury. Neurochem. Int. 30 (1997) 375-383
33. Sosin D.M., Sniezek J.E., and Waxweiler R.J. Trends in death associated with traumatic brain injury, 1979 through 1992. Success and failure. JAMA 273 (1995) 1778-1780
34. Stahel P.F., and Barnum S.R. The role of the complement system in inflammatory CNS diseases. Expert Rev. Clin. Immunol. 2 (2006) 445-456
35. Stroemer R.P., and Rothwell N.J. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 17 (1997) 597-604
36. Stroemer R.P., and Rothwell N.J. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat. J. Cereb. Blood Flow Metab. 18 (1998) 833-839
37. Tehranian R., Andell-Jonsson S., Beni S.M., Yatsiv I., Shohami E., Bartfai T., Lundkvist J., and Iverfeldt K. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J. Neurotrauma 19 (2002) 939-951
38. Thurman D.J., Alverson C., Dunn K.A., Guerrero J., and Sniezek J.E. Traumatic brain injury in the United States: a public health perspective. J. Head Trauma Rehabil. 14 (1999) 602-615
39. West M.J., and Gundersen H.J. Unbiased stereological estimation of the number of neurons in the human hippocampus. J. Comp. Neurol. 296 (1990) 1-22
40. Wheeler R.D., Boutin H., Touzani O., Luheshi G.N., Takeda K., and Rothwell N.J. No role for interleukin-18 in acute murine stroke-induced brain injury. J. Cereb. Blood Flow Metab. 23 (2003) 531-535
41. Xu H., Barks J.D., Schielke G.P., and Silverstein F.S. Attenuation of hypoxia-ischemia-induced monocyte chemoattractant protein-1 expression in brain of neonatal mice deficient in interleukin-1 converting enzyme. Brain. Res. Mol. Brain Res. 90 (2001) 57-67
42. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., and Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26 (1995) 676-681
43. Yatsiv I., Morganti-Kossmann M.C., Perez D., Dinarello C.A., Novick D., Rubinstein M., Otto V.I., Rancan M., Kossmann T., Redaelli C.A., Trentz O., Shohami E., and Stahel P.F. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J. Cereb. Blood Flow Metab. 22 (2002) 971-978